Cargando…

Patterns of anticoagulation therapy in atrial fibrillation: results from a large real-life single-center registry

AIM: To investigate the differences in the characteristics and clinical outcomes of recently diagnosed patients with atrial fibrillation (AF) receiving different types of anticoagulants in a real-life setting. METHODS: We retrospectively analyzed the charts of 1000 consecutive patients with non-valv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jurin, Ivana, Lucijanić, Marko, Šakić, Zrinka, Hulak Karlak, Vanja, Atić, Armin, Magličić, Ana, Starčević, Boris, Hadžibegović, Irzal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684544/ https://www.ncbi.nlm.nih.gov/pubmed/33150762 http://dx.doi.org/10.3325/cmj.2020.61.440

Ejemplares similares

Red cell distribution width is a potent prognostic parameter for in-hospital and post-discharge mortality in hospitalized coronavirus disease 2019 patients: a registry-based cohort study on 3941 patients
por: Lucijanić, Marko, et al.
Publicado: (2022)

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

Incidence and risk factors for venous and arterial thromboses in hospitalized patients with coronavirus disease 2019: data on 4014 patients from a tertiary center registry
por: Jurin, Ivana, et al.
Publicado: (2022)

The associations of age, sex, and comorbidities with survival of hospitalized patients with coronavirus disease 2019: data from 4014 patients from a tertiary-center registry
por: Piskač Živković, Nevenka, et al.
Publicado: (2022)

P1691: COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID-19 PATIENTS
por: Lucijanic, M., et al.
Publicado: (2022)

Vaccine uptake in caregivers family members and patients with dementia and relationship with severity of dementia and caregiver burden: a cross-sectional study
por: Lucijanic, Jelena, et al.
Publicado: (2023)

Cardiovascular mortality in liver and kidney transplant recipients: A retrospective analysis from a single institution
por: Sertić, Zrinka, et al.
Publicado: (2021)

High red cell distribution width at the time of ST segment elevation myocardial infarction is better at predicting diastolic than systolic left ventricular dysfunction: A single-center prospective cohort study
por: Ćatić, Jasmina, et al.
Publicado: (2018)

The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
por: ten Cate, V., et al.
Publicado: (2016)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Erratum to: The Global Anticoagulant Registry in the FIELD – Atrial Fibrillation (GARFIELD-AF): Exploring the changes in anticoagulant practice in patients with non-valvular atrial fibrillation in the Netherlands
por: ten Cate, V., et al.
Publicado: (2016)

Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry
por: Kapłon-Cieślicka, Agnieszka, et al.
Publicado: (2022)

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
por: Liang, Hai-Feng, et al.
Publicado: (2019)

Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
por: Angeli, Fabio, et al.
Publicado: (2023)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
por: Murakawa, Yuji, et al.
Publicado: (2017)

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF)
por: Sun, Yihong, et al.
Publicado: (2019)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry
por: Hamatani, Yasuhiro, et al.
Publicado: (2015)

Anticoagulation in patients with atrial fibrillation and heart failure: Insights from the NCDR PINNACLE‐AF registry
por: Contreras, Johanna P., et al.
Publicado: (2019)

Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry
por: Sciria, Christopher T., et al.
Publicado: (2020)

Survival after hospital discharge in patients hospitalized for acute coronavirus disease 2019: data on 2586 patients from a tertiary center registry
por: Lucijanić, Marko, et al.
Publicado: (2022)

Results from the Registry of Atrial Fibrillation (AFABE): Gap between Undiagnosed and Registered Atrial Fibrillation in Adults—Ineffectiveness of Oral Anticoagulation Treatment with VKA
por: Panisello-Tafalla, Anna, et al.
Publicado: (2015)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Differences in Immunoglobulin G Glycosylation Between Influenza and COVID-19 Patients
por: Kljaković-Gašpić Batinjan, Marina, et al.
Publicado: (2022)

Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT‐AF I) Registry
por: O'Brien, Emily C., et al.
Publicado: (2016)

Increased bone mineral density in postmenopausal women with type 2 diabetes mellitus
por: Hadzibegovic, Irzal, et al.
Publicado: (2008)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Szpotowicz, Anna, et al.
Publicado: (2021)

Use of Oral Anticoagulation Therapy in Atrial Fibrillation after Stroke: Results from a Nationwide Registry
por: Jespersen, Stine Funder, et al.
Publicado: (2013)

Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry
por: Okumura, Yasuo, et al.
Publicado: (2017)

Oral Anticoagulant Use in Elderly Japanese Patients With Non-Valvular Atrial Fibrillation　― Subanalysis of the ANAFIE Registry ―
por: Akao, Masaharu, et al.
Publicado: (2020)

Oral Anticoagulants in Very Elderly Nonvalvular Atrial Fibrillation Patients With High Bleeding Risks: ANAFIE Registry
por: Okumura, Ken, et al.
Publicado: (2022)

Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry
por: Park, Hanjin, et al.
Publicado: (2023)

Outcomes of patients with atrial fibrillation on oral anticoagulation with and without heart failure: the ETNA-AF-Europe registry
por: Schnabel, Renate B, et al.
Publicado: (2023)

Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: A multicenter registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2019)

Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2022)

IgG N-glycome changes during the course of severe COVID-19: An observational study
por: Petrović, Tea, et al.
Publicado: (2022)

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis
por: Bistrovic, Petra, et al.
Publicado: (2022)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
por: Calderon, Jose Miguel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8cknn8tqmv5q632pi7skr3okbt